Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT00432094Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT02500472Investigation of Kava Effects on NNK Metabolism
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT00365287Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT00625092Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies
NCT05705700Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT01215981Influenza Vaccine Post Allogeneic Transplant
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT05308316Sugars in Cigarettes
NCT05120570PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
NCT06030648MT2022-01: MSCs for ALD
NCT01171469Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
NCT06772090Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT00005987Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
NCT01173016Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
NCT02989844Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
NCT00602693T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT03998735Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT05114837Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT02370160HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma
NCT03081780Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT03637972COMET2 Project 1 Filter Ventilation Study
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT00176930Stem Cell Transplant for Hematological Malignancy
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer